Structure Therapeutics (NASDAQ:GPCR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Structure Therapeutics (GPCR) operate in?

Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Structure Therapeutics Stock (NASDAQ: GPCR) stock price, news, charts, stock research, profile.

Open	$28.53
Close	-
Volume / Avg.	182.23K / 839.71K
Day Range	$27.78 - $29.08
52 Wk Range	26.23 - 62.74
Market Cap	$1.62B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	21.87%
Days to Cover	11.34

Recent News

Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition

Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised concerns over the Catalent acquisition.

Vandana Singh

Can Roche Challenge Lilly and Novo in the Weight Loss Market?

Over the last couple of years, one of the biggest stories in the stock market has been around pharmaceutical companies that are thriving due to the proliferation of their weight loss drug treatments. The two firms that

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$28.53
Close	-
Volume / Avg.	182.23K / 839.71K
Day Range	$27.78 - $29.08
52 Wk Range	26.23 - 62.74
Market Cap	$1.62B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	21.87%
Days to Cover	11.34

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Structure Therapeutics (GPCR) stock?

You can purchase shares of Structure Therapeutics (NASDAQ:GPCR) through any online brokerage.

View our list of the best stock brokerages

Who are Structure Therapeutics (GPCR) competitors?

Other companies in Structure Therapeutics’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS) and Phibro Animal Health (NASDAQ:PAHC).

What is the forecast, or price target, for Structure Therapeutics (GPCR) stock?

Structure Therapeutics has a consensus price target of $78.10.

What is the current price for Structure Therapeutics (GPCR)?

The stock price for Structure Therapeutics (NASDAQ: GPCR) is $28.325 last updated December 23, 2024 at 10:40 AM EST.

Does Structure Therapeutics (GPCR) pay a dividend?

There are no upcoming dividends for Structure Therapeutics.

When is Structure Therapeutics (NASDAQ:GPCR) reporting earnings?

Structure Therapeutics’s Q4 earnings are confirmed for Friday, March 7, 2025.

Is Structure Therapeutics (GPCR) going to split?

There is no upcoming split for Structure Therapeutics.

What sector and industry does Structure Therapeutics (GPCR) operate in?

Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Structure Therapeutics

Structure Therapeutics (GPCR) Forecast